Abstract
To save egg yolk immunoglobulin (IgY) from damage by protease digestion in oral delivery, IgY specific to enterovirus 71 (EV71) was loaded into polypeptide microcapsules by the method of layer-by-layer encapsulation. Porous CaCO3 particles doped with IgY were used as templates which were coated with multilayer poly (L-lysine) (PLL) and poly (L-glutamic acid) (PGA). Then, IgY-loaded polypeptide microcapsules were fabricated after the removal of CaCO3 templates. The alternating adsorption was confirmed by the zeta potential and the successful formation of a multilayer polypeptide (PLL/PGA) shell was visualized by SEM. The influence of the PLL/PGA layer numbers on the IgY sustained release performance was studied in simulated gastric fluid. IgY release could be accurately controlled by adjusting the layer number of the polypeptide shells and only 45% of the IgY was released from 5-bilayer microcapsules in the initial 2 hours. The biological activity of the encapsulated IgY was investigated both in vitro and in vivo. Encapsulated EV71-specific IgY remained highly active and capable of neutralizing EV71 after multilayer polypeptide encapsulation, which provided a promising method to protect EV71-specific IgY in the gastric environment and to specifically release IgY at the target intestinal site for the prevention and control of EV71 infectious diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
